GEn1E Lifesciences

Palo Alto, CA · Founded 2018 · Privately Held (backing)

Developer of artificial intelligence-powered precision therapies designed to address immunology, inflammatory, rare, and oncologic diseases. GEn1E Lifesciences is based in Palo Alto, CA and was founded in 2018. It was valued at $136 million at its early-stage round in Dec 2025, the last priced event on record. It has raised $25.6 million across 2 recorded rounds; the latest was a $5.5 million early-stage round in Oct 2025.

PMV mark · valuation
$135.5M
Oct 2026
Priced at
its early-stage round
Dec 2025
Total raised
$25.6M
Last round
Early Stage VC
Oct 2025
How much has GEn1E Lifesciences raised?
$25.6Macross 2 recorded rounds · Dec 2022 – Oct 2025

Most recently, GEn1E Lifesciences raised $5.5M in its Early Stage VC (Oct 2025).

Free account
More of GEn1E Lifesciences with a free account
  • ·The complete investor list: 38 names
  • ·Watch GEn1E Lifesciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

GEn1E Lifesciences round by round

2 rounds
Oct 2025Early Stage VC$5.5MSEC filing▮
44 investors participated
Dec 2022Early Stage VC$17.0MSEC filing▮
89 investors participated

How much has GEn1E Lifesciences raised?

GEn1E Lifesciences has raised $25.6 million across 2 recorded rounds since 2022. The largest was a $5.5 million early-stage round in Oct 2025.

GEn1E Lifesciences has filed 1 Form D with the SEC, most recently in Dec 2022 ($17 million sold to 89 investors).

GEn1E Lifesciences investors

38 investors are on record for GEn1E Lifesciences, including Y Combinator, Khosla Ventures, Gaingels and StartX (US). The early-stage round in Oct 2025 drew 44 investors.

For fundraisers
Raising for a company like GEn1E Lifesciences?

38 investors have backed GEn1E Lifesciences.

See all 38 investors →

Frequently asked about GEn1E Lifesciences

How much has GEn1E Lifesciences raised?
GEn1E Lifesciences has raised $25.6M in total across 2 recorded funding rounds.
When was GEn1E Lifesciences's last funding round?
GEn1E Lifesciences's most recent recorded round was Early Stage VC in Oct 2025, raising $5.5M.